COVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researchers. This could affect responses to secondary infections. The SARS-CoV-2
Caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues to spread across the globe. The rise to dominance of
COVID-19, the source of the current pandemic, may be caused by a single virus, but it has a variety of presentations that make treatment difficult. Children, for example,
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROFERON-A 170927 Pre Filled Syringes contains the active ingredient interferon alfa-2a (rbe) Consumer Medicine Information
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PEGASYS® 180710 pronounced peg-ah-sis contains the active ingredient peginterferon alfa-2a Consumer Medicine Information What is
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. REVLIMID® (lenalidomide) Consumer Medicine Information WARNING: Revlimid (lenalidomide) is structurally related to ‘thalidomide’, which is
A new study that measured the reliability of administering antibiotics before obtaining blood cultures could end the debate among physicians regarding sepsis management. Seven emergency departments across North
Researchers have developed an animal model to test HIV infection and therapies in infants, allowing them to develop biomarkers to predict viral rebound after antiretroviral therapy (ART) interruption.
By mapping out more than 100,000 immune cells in patients with Crohn’s disease, Mount Sinai researchers have discovered a signature of cells that are involved in a type
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
